All ETFs

PHLCX

ETF

PHLCX · UNKNOWN · 43 holdings

9,47 €

▲ 0,16 € (1,72%)

Day Range

—

52-Week Range

—

Volume

—

Ouverture —

Moyenne 50J / 200J

—

Moyenne 50J / 200J

—

About PHLCX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: 9,31 €
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 88.4%
HHI Score: 423,79
Top Sector: Healthcare (77.956435%)

Performance

Moderate (23,4%) ↗ Recovering

▲ 2,36%

▼ -0,10%

▼ -2,56%

▼ -23,70%

YTD

▼ -2,46%

▼ -13,36%

▼ -43,04%

Positive 1W (+2.36%) after negative 1M (-0.1%) — trend may be reversing

Price History

Concentration Risk

49,69% Moderately Concentrated

Diversified Concentrated

The top 10 holdings represent 49,69% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size

LLY

▼ -1,65%

VRTX

▼ -2,34%

ARGX

▼ -0,11%

NBIX

▼ -2,09%

AZN

▼ -0,47%

TMO

▼ -0,87%

NVO

▲ 0,21%

ALNY

▲ 0,26%

UNH

▼ -0,84%

▼ -1,62%

Weighted avg. of top holdings ▼ -1,14%

Sector Allocation

Healthcare

77,96%

Financial Services

2,68%

Manufacturing

0,19%

Top 10 Holdings

49,69% of fund

LLY Eli Lilly & Co

14,59%

VRTX Vertex Pharmaceuticals Inc

4,95%

ARGX Argenx SE

4,84%

NBIX Neurocrine Biosciences Inc

4,78%

AZN AstraZeneca PLC

4,64%

TMO Thermo Fisher Scientific Inc

3,57%

NVO Novo Nordisk A/S

3,49%

ALNY Alnylam Pharmaceuticals Inc

3,14%

UNH UnitedHealth Group Inc

2,85%

EW Edwards Lifesciences Corp

2,84%

Other positions

10,89%

All Holdings (43)

Top 10: 49,69% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	LLY	Eli Lilly & Co	14,59%	265 302	195,71 M
2	VRTX	Vertex Pharmaceuticals Inc	4,95%	150 218	66,40 M
3	ARGX	Argenx SE	4,84%	113 310	64,96 M
4	NBIX	Neurocrine Biosciences Inc	4,78%	520 854	64,08 M
5	AZN	AstraZeneca PLC	4,64%	854 038	62,20 M
6	TMO	Thermo Fisher Scientific Inc	3,57%	118 988	47,93 M
7	NVO	Novo Nordisk A/S	3,49%	655 469	46,87 M
8	ALNY	Alnylam Pharmaceuticals Inc	3,14%	138 476	42,17 M
9	UNH	UnitedHealth Group Inc	2,85%	126 565	38,21 M
10	EW	Edwards Lifesciences Corp	2,84%	487 173	38,11 M
11	VRNA	Verona Pharma PLC	2,81%	464 168	37,69 M
12	UCB	UCB SA	2,68%	197 591	35,95 M
13	LONN	Lonza Group AG	2,55%	49 206	34,14 M
14	ABT	Abbott Laboratories	2,34%	234 734	31,36 M
15	ARQT	Arcutis Biotherapeutics Inc	2,21%	2,27 M	29,59 M
16	INSM	Insmed Inc	2,09%	401 806	28,02 M
17	CVS	CVS Health Corp	2,04%	428 269	27,43 M
18	DHR	Danaher Corp	1,99%	140 737	26,73 M
19	GEHC	GE HealthCare Technologies Inc	1,88%	358 242	25,27 M
20	DXCM	Dexcom Inc	1,59%	249 266	21,39 M
21	CRNX	Crinetics Pharmaceuticals Inc	1,54%	675 458	20,61 M
22	RVTY	Revvity Inc	1,48%	219 203	19,82 M
23	BPMC	Blueprint Medicines Corp	1,38%	183 012	18,55 M
24	TARS	Tarsus Pharmaceuticals Inc	1,23%	382 765	16,44 M
25	STMN	Straumann Holding AG	1,10%	114 927	14,78 M
26	TNDM	Tandem Diabetes Care Inc	1,08%	732 318	14,51 M
27	NAMS	Newamsterdam Pharma Co NV	1,05%	777 280	14,08 M
28	PCVX	Vaxcyte Inc	0,94%	388 884	12,63 M
29	XENE	Xenon Pharmaceuticals Inc	0,88%	407 083	11,74 M
30	STVN	Stevanato Group SpA	0,87%	523 209	11,62 M
31	APLS	Apellis Pharmaceuticals Inc	0,87%	686 301	11,62 M
32	MLYS	Mineralys Therapeutics Inc	0,86%	738 891	11,51 M
33	ISRG	Intuitive Surgical Inc	0,62%	15 086	8,33 M
34	KYMR	Kymera Therapeutics Inc	0,61%	274 195	8,13 M
35	SION	Sionna Therapeutics Inc	0,57%	553 942	7,58 M
36	MTSR	Metsera Inc	0,44%	221 101	5,91 M
37	TVTX	Travere Therapeutics Inc	0,44%	393 263	5,91 M
38	VERA	Vera Therapeutics Inc	0,35%	247 916	4,70 M
39	A	Agilent Technologies Inc	0,31%	36 977	4,14 M
40	APGE	Apogee Therapeutics Inc	0,31%	112 496	4,12 M
41	CABA	Cabaletta Bio Inc	0,19%	1,38 M	2,58 M
42	KMTS	Kestra Medical Technologies Lt	0,08%	48 217	1,09 M
43	BBNX	Beta Bionics Inc	0,06%	43 415	748 474,6

Showing top 10 of 43 holdings · Listed: 89,11% · 10,89% in other positions

Related ETFs